GLP-1 drugs can produce major weight loss, but their wider impact will depend on affordable treatment and appropriate support.
Articles on Semaglutide
Displaying 1 - 20 of 52 articles
On top of the risks of injecting untested and potentially contaminated products, user error may make this runaway wellness fad even more dangerous.
Some research suggests between 10% and 30% of GLP-1 drug users may be considered non-responders.
Ozempic-style drugs have been flagged as possible treatments for cancer, dementia, endo, addiction and more. An expert explains what the evidence really says.
The thriving market in online, counterfeit GLP-1 drugs that do not meet FDA criteria poses serious risks to consumers.
In a clinical trial, this small-molecule drug was found to be superior to semaglutide for lowering blood sugar.
A major study links Wegovy to a rare form of sudden vision loss, and finds men may face three times the risk of women.
Weight-loss injections like Ozempic may help cancer patients with brain tumours live longer. But experts urge caution before drawing firm conclusions.
GLP-1 drugs are the first medication to show promise for treating addiction to a wide range of substances.
Feeling full isn’t the same as losing weight.
Australia’s regulator has issued warnings about the risk of suicidal thoughts and lower effectiveness of contraceptives in those taking Ozempic, Wegovy and Mounjaro.
Two major trials show the weight-loss drug offers no cognitive benefit to people with early Alzheimer’s, dashing hopes it might protect the brain.
Weight doesn’t tell us the whole story about a person’s risk for poor health.
Semaglutide (better known as Wegovy) may help people with obesity lose up to 25% of their body weight when used at a higher dose.
A new study shows drugs such as Ozempic come with a small but increased risk of a condition known as an ‘eye stroke’.
Women who use an oral contraceptive might want to consider using a back-up method after starting a weight loss drug.
These annoying side-effects could potentially cause permanent damage to your teeth.
While natural approaches to raising GLP-1 are not as potent as medications, they provide a drug-free approach to weight loss and healthy eating.
There are a number of reasons people are ‘microdosing’ weight-loss drugs. But here’s what to consider before you try it.
Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health conditions.
Top contributors
-
Associate Professor of Metabolic Medicine, University of Surrey
-
Professor of Pharmaceutical Chemistry, Macquarie University
-
Professor of Community Health and Wellbeing, The University of Queensland
-
Accredited Practising Dietitian and Lecturer, Southern Cross University
-
Associate Professor of Physiology and Medical Education, Anglia Ruskin University
-
General Practitioner, PhD Candidate, Bond University
-
Head of the Translational Nanomedicine & Biotherapeutics Group and Senior Research Fellow, Adelaide University
-
Distinguished Professor of Pharmacy Practice, University of Connecticut
-
ARC Future Fellow, School of Biomedical Sciences, The University of Queensland
-
Laureate Professor in Nutrition and Dietetics, University of Newcastle
-
Assistant Professor, Critical Disability Studies, Carleton University
-
Senior Lecturer, Nutrition and Food Science, Australian Catholic University
-
Clinical Epidemiologist, Washington University in St. Louis
-
Adjunct Senior Research Fellow, Global and Women's Health, School of Public Health & Preventive Medicine, Monash University
-
Research Lead/Advanced Clinical Practitioner/Senior Research Fellow, University of Bradford